FeesSafety
Pluang+

ZenaTech wins $503K in new drone survey contracts for Mid-Atlantic DOT infrastructure projects.

Market News
10 Nov 2026, 14:45 WIB
GlobeNewsWire
View Source
Bullish
ZenaTech wins $503K in new drone survey contracts for Mid-Atlantic DOT infrastructure projects.

ZenaTech secured three new government contracts worth approximately $503,000 for drone-based surveying on transportation infrastructure projects in the Mid-Atlantic region. These contracts support highway, intersection, and bridge construction projects valued at about $13.2 million, contributing to nearly $65 million in total project work funded by federal and state transportation programs. ZenaTech's Drone as a Service platform uses AI-powered drones to improve survey accuracy and safety while reducing time spent near traffic. The company plans to expand its drone services in transportation projects as adoption grows among agencies and contractors.

ZenaTech’s recent contracts total approximately $503,000 in revenue for drone surveying services on transportation projects. For readers following the Technology sector, here is Pluang's market snapshot as of Nov 10, 2026 19:03 WIB: out of 150 priced US Technology stocks, 45 rose and 99 fell. Notable movers include KLTR at USD 1.68 (+17.48%), BTDR at USD 7.03 (+6.35%, with 80% buy orders), and ASX at USD 36.38 (+5.88%).

More News

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

The 2026 Verizon Data Breach Investigations Report links 61% of manufacturing breaches to third parties and 81% to internal data compromise. Manufacturers adopting Microsoft 365 Copilot should carefully manage which engineering and supplier files emp...

Market News
Neutral
1 hour ago
Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health has been selected as a specialty pharmacy partner for Pasatru™ (garetosmab-grts), Regeneron's FDA-approved treatment for adults with fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. Pasatru™ is the first treat...

Market News
Bullish
1 hour ago
PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera raised $25 million in financing led by new investors AbbVie Ventures and Lumination Capital, alongside existing backers. The funds will support development of its oral small molecule TNFα inhibitor and advance its oral TL1A inhibitors into l...

Company Fundamentals
Bullish
1 hour ago
Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollm...

Company Fundamentals
Bullish
1 hour ago
Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App